Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) SHH

6.82

-0.09(-1.30%)

Updated at June 03 10:50AM

Currency In CNY

Valuation

Market Cap8.39B
Enterprise Value9.68B
P/E Ratio-4.01
PEG Ratio0.01
Price/Sales Ratio12.74
Price/Book Ratio1.07
Enterprise/Revenue16.63
Enterprise/EBITDA-4.81

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-3.18
Operating Margin-2.05

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.24

Income Statement

Revenue798.06M
Revenue/Share0.54
Gross Profit-22.06M
EBITDA-1.31B
Net Income-1.37B
Diluted EPS-1.45

Balance Sheet

Total Cash54.53M
Total Cash/Share0.06
Total Debt2.04B
Total Debt/Equity0.33
Current Ratio1.38
Book Value Per Share6.52

Price History

52-Week Change-40.07
52-Week High13.48
52-Week Low6.42
Moving Average 50 Days7.06
Moving Average 200 Days9.3

Statistics

Average Volume16.22M
Shares Outstanding940.86M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield2.17
Payout Ratio-0.06
Last Split Factor2:1
Last Split DateJune 13, 2016